BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25748248)

  • 1. Development of an acid ceramidase activity-based probe.
    Ouairy CM; Ferraz MJ; Boot RG; Baggelaar MP; van der Stelt M; Appelman M; van der Marel GA; Florea BI; Aerts JM; Overkleeft HS
    Chem Commun (Camb); 2015 Apr; 51(28):6161-3. PubMed ID: 25748248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the activation of acid ceramidase.
    Gebai A; Gorelik A; Li Z; Illes K; Nagar B
    Nat Commun; 2018 Apr; 9(1):1621. PubMed ID: 29692406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase.
    He X; Schuchman EH
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.
    Momoi T; Ben-Yoseph Y; Nadler HL
    Biochem J; 1982 Aug; 205(2):419-25. PubMed ID: 6814427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.
    Mao C; Obeid LM
    Biochim Biophys Acta; 2008 Sep; 1781(9):424-34. PubMed ID: 18619555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular medicine of acid ceramidase.
    Frohbergh M; He X; Schuchman EH
    Biol Chem; 2015 Jun; 396(6-7):759-65. PubMed ID: 25938220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.
    Kono M; Dreier JL; Ellis JM; Allende ML; Kalkofen DN; Sanders KM; Bielawski J; Bielawska A; Hannun YA; Proia RL
    J Biol Chem; 2006 Mar; 281(11):7324-31. PubMed ID: 16380386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reverse activity of human acid ceramidase.
    Okino N; He X; Gatt S; Sandhoff K; Ito M; Schuchman EH
    J Biol Chem; 2003 Aug; 278(32):29948-53. PubMed ID: 12764132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
    Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
    Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between bioeffector characteristics of sphingolipids and the structure of their hydrophobic fragment.
    Dyatlovitskaya EV
    Biochemistry (Mosc); 1998 Jan; 63(1):55-61. PubMed ID: 9526095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramidases, roles in sphingolipid metabolism and in health and disease.
    Coant N; Sakamoto W; Mao C; Hannun YA
    Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
    Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
    Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase.
    He X; Dagan A; Gatt S; Schuchman EH
    Anal Biochem; 2005 May; 340(1):113-22. PubMed ID: 15802137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
    Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
    J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.
    Blachnio-Zabielska A; Baranowski M; Zabielski P; Gorski J
    J Cell Physiol; 2010 Nov; 225(3):786-91. PubMed ID: 20568228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification, and characterization of a recombinant neutral ceramidase from Mycobacterium tuberculosis.
    Okino N; Ikeda R; Ito M
    Biosci Biotechnol Biochem; 2010; 74(2):316-21. PubMed ID: 20139604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDase is a pan-ceramidase in Drosophila.
    Yuan C; Rao RP; Jesmin N; Bamba T; Nagashima K; Pascual A; Preat T; Fukusaki E; Acharya U; Acharya JK
    Mol Biol Cell; 2011 Jan; 22(1):33-43. PubMed ID: 21148295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
    Morad SA; Cabot MC
    Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
    Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
    Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2n-fatty acids from phosphatidylcholine label sphingolipids--a novel role of phospholipase A2?
    Meyer SG; Karow W; de Groot H
    Biochim Biophys Acta; 2005 Jun; 1735(1):68-78. PubMed ID: 15950537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.